A Pilot Study of a Novel through-the-Scope Self-Expandable Metallic Airway Stents Delivery System in Malignant Central Airway Obstruction
Table 1
Baseline characteristics of all patients.
Total ()
BST ()
Combined therapy ()
Local anesthesia ()
General anesthesia ()
Age (years)
65.8 ± 10.8
63.4 ± 13.9
67.5 ± 8.4
65.1 ± 8.6
66.3 ± 12.1
Gender (male/female)
17/8
5/5
12/3
7/2
6/10
Malignancy
25
10
15
Squamous
8
1
7
5
3
Adenocarcinoma
7
5
2
1
6
SCLC
1
1
—
1
0
Esophagus cancer
6
2
4
1
5
Other cancers
3
1
2
1
2
Obstruction location
Trachea
9
3
6
3
6
RMB or LMB
10
2
8
4
6
RMB + LMB
2
1
1
1
1
Trachea + RMB/LMB/RBI
4
−1
3
Types of stenosis
Extrinsic obstruction
5
3
2
1
4
Mixed
26
12
14
9
17
Anesthesia
Local anesthesia
9
4
5
9
—
Laryngeal mask
9
5
4
—
Intubation
7
4
3
—
Combined therapy
Chemo/TKI
4
—
3
1
RT
6
—
2
4
RT + Chemo/TKI
5
—
2
BST
10
10
—
8
COPD: chronic obstructive pulmonary disease; CHD: coronary heart disease; SCLC: small cell lung carcinoma; Chemo: chemotherapy; RT: radiotherapy; TKI: tyrosine kinase inhibitor; BST: best support therapy; RMB = right main bronchus; LMB = left main bronchus; RBI = right bronchus intermedius; BST: best support therapy.
